← All trials
NCT06807905
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2019
- Primary completion
- Sep 1, 2020
- Completion date
- Feb 1, 2021
- First posted
- Feb 4, 2025
- Last posted
- Feb 4, 2025
- Enrollment
- 20
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of LjubljanaLead sponsor
- University of LjubljanaSponsor investigator
- University of LjubljanaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.